PELLFICURE PHARMACEUTICALS INC has a total of 33 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are ZHEJIANG POLY PHARMACEUTICAL CO LTD, LIPOPHARMA THERAPEUTICS S L and BEIJING TIANHENG DRUG RES INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 5 | |
#4 | Canada | 4 | |
#5 | EPO (European Patent Office) | 4 | |
#6 | Republic of Korea | 3 | |
#7 | Brazil | 1 | |
#8 | China | 1 | |
#9 | Hong Kong | 1 | |
#10 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Borgstrom Per | 17 |
#2 | Borgström Per | 11 |
#3 | Chrastina Adrian | 11 |
#4 | Baron Veronique Therese | 8 |
#5 | Abedinpour Parisa | 6 |
#6 | Baron Veronique | 4 |
#7 | Borgstroem Per | 4 |
Publication | Filing date | Title |
---|---|---|
WO2018195202A1 | Compositions and methods for the treatment of cancer | |
WO2018080933A1 | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione | |
US2017283374A1 | Compositions and methods for treatment of prostate carcinoma | |
EP2968219A1 | Novel therapy for prostate carcinoma | |
KR20160010889A | Combination therapy for the treatment of prostate carcinoma |